Hält derzeit Positionen bei Adynxx Inc and Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Adynxx Inc | None - |
Independent Chairman of the Board | Syndax Pharmaceuticals Inc | 1. Dezember 2008 - |
Director | Euthymics Bioscience Inc | 4. April 2006 - 1. Januar 2012 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2022-09-16 | 2022-09-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
6.556
-8.0%
23,43153.625 USD |
6.556 -8.0% | 23,43 | 153.625 USD | |
2022-09-16 | 2022-09-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
5.419
-6.7%
23,43126.982 USD |
5.419 -6.7% | 23,43 | 126.982 USD | |
2022-09-16 | 2022-09-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
66.840
-46.9%
24,201.617.381 USD |
66.840 -46.9% | 24,20 | 1.617.381 USD | |
2021-04-22 | 2021-04-22 |
Syndax Pharmaceuticals Inc
(SNDX)
|
K Kauf |
13.967
+47.6%
14,11197.077 USD |
13.967 +47.6% | 14,11 | 197.077 USD |